Christian Strassburg

Title: Christian Strassburg: Innovator in Cancer Risk Prediction

Introduction

Christian Strassburg is a notable inventor based in Hannover, Germany. He has made significant contributions to the field of medical diagnostics, particularly in the prediction of cancerous diseases and inflammatory intestinal diseases. His innovative approach utilizes genetic testing to assess risk potential, which can lead to early diagnosis and treatment.

Latest Patents

Strassburg holds a patent for a method that predicts the risk potential for cancerous diseases and inflammatory intestinal diseases. The patent, titled "Method for the prediction of the risk potential for cancerous diseases and inflammatory intestinal diseases and corresponding tests," involves testing a DNA sample for the presence of the polymorphic UGT1A7 allele. A positive result indicates a sensitivity to cancerous diseases, while similar predictions can be made for inflammatory intestinal diseases. The method employs PCR amplification of exon 1, followed by sequence analysis to compare the determined sequence with that of the wild type and the polymorphic allele. The presence or absence of mutations is monitored through automated fluorescent dye sequencing.

Career Highlights

Christian Strassburg is affiliated with the Medizinische Hochschule Hannover, where he conducts research and develops innovative diagnostic methods. His work has the potential to significantly impact the early detection and treatment of serious health conditions.

Collaborations

Strassburg collaborates with Michael Manns, contributing to advancements in medical research and diagnostics.

Conclusion

Christian Strassburg's innovative methods in predicting cancer risk highlight the importance of genetic testing in modern medicine. His contributions pave the way for improved diagnostic techniques and better patient outcomes.